ReportDrug Delivery

A once-a-month oral contraceptive

See allHide authors and affiliations

Science Translational Medicine  04 Dec 2019:
Vol. 11, Issue 521, eaay2602
DOI: 10.1126/scitranslmed.aay2602

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

When less is more

Reducing the frequency at which a patient must take a medication can improve patient adherence. Kirtane et al. developed an ingestible gastric resident dosage form that releases the contraceptive levonorgestrel. Levonorgestrel was detected in the serum of pigs for 1 month after oral administration of a single dose. These preliminary results demonstrate progress that is an easy pill to swallow.

Abstract

Poor patient adherence to oral contraceptives is the predominant cause of failure of these therapies, leading to unplanned pregnancies that can negatively affect female health worldwide. To improve patient adherence, we developed an oral contraceptive that is administered once a month. Here, we describe the design and report in vivo characterization of a levonorgestrel-releasing gastric resident dosage form in pigs.

View Full Text

Stay Connected to Science Translational Medicine